A phase I, pharmacokinetic and pharmacodynamic study of nimotuzumab in Japanese patients with advanced solid tumors

By Okamoto Wataru   Yoshino Takayuki   Takahashi Toshiaki   Okamoto Isamu   Ueda Shinya   Tsuya Asuka   Boku Narikazu   Nishio Kazuto   Fukuoka Masahiro   Yamamoto Nobuyuki   Nakagawa Kazuhiko  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 1063-1071

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors

By Plummer Ruth   Madi Ayman   Jeffels Melinda   Richly Heike   Nokay Bahar   Rubin Stephen   Ball Howard   Weller Steve   Botbyl Jeffrey   Gibson Diana   Scheulen Max  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 93-101

Springer Publishing Company

Access to resources Recommend Favorite

A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors

By Yan Zhao   Zhu Zhongling   Li Kai   Chen Peng   Wang Liuchun   Huang Chun   Xue Jinhuai   Liu Meijun  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 955-961

Springer Publishing Company

Access to resources Recommend Favorite

A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors

By Hurwitz Herbert   Cohen Roger   McGovren J.   Hirawat Samit   Petros William   Natsumeda Yutaka   Yoshinari Tomoko  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 1, 2007-01 ,pp. : 139-147

Springer Publishing Company

Access to resources Recommend Favorite

Phase I dose escalation study of docetaxel with filgrastim support in patients with advanced solid tumors

By Masters Gregory   Brockstein Bruce   Mani Sridhar   Ratain Mark  

Medical Oncology, Vol. 20, Iss. 1, 2003-03 ,pp. : 7-12

Humana Press, Inc

Access to resources Recommend Favorite